|
|
| Begins |
September 19, 2005
|
|
|
|
|
|
|
|
| Email |
customercare@americanconference.com
|
|
| Category |
Health: Pharmacy
|
|
|
|
|
|
|
| Contact |
41 West 25th Street, 9th Fl
NY, NY 10010
|
|
|
|
|
|
| Description |
With these challenges facing those in the clinical trial arena in mind, American Conference Institute has designed the 3rd National Forum on Managing Legal Risks in Conducting & Promoting Clinical Trials. This event was so successful in February in New York City that American Conference Institute has rolled it out to capture the West Coast audience. This forum will respond specifically to the most pressing concerns of those charged with managing their company's conduct of clinical trials. The experienced and successful faculty of senior food and drug lawyers; regulatory attorneys and in-house counsel will provide insight on the most challenging regulatory, litigation and compliance issues, including:
* Critical analysis of FDAMA 113 — what must you disclose?
* Understanding the key provisions of PhRMA's code of conduct for clinical trials
* Protecting your IP by knowing what clinical trial information shouldn’t be disclosed
* The SSRI efficacy study — how it will impact pharma, biotech and device r&d
* Using clinical data to promote off-label use
Industry — sponsored research: what you must know to avoid claims of fraud and conflict
Using clinical trial data to support post-marketing claims
* Building successful and effective relationships with CROs
* Compliant and successful conduct of international clinical trials
|
|
|
|
